Description

Pyrrolo[3,4-D]Imidazole-5(1H)-Butyric Acid, Hexahydro-4-Methyl-2-Oxo-, Stereoisomer (8Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its complex fused heterocyclic structure. This compound is of significant value in modern organic synthesis, particularly for constructing novel molecular scaffolds with potential biological activity. It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of new active pharmaceutical ingredients (APIs) and fine chemicals. CAS No. 802611-55-8.

Application

This specialized intermediate serves critical roles in sophisticated chemical synthesis pipelines. Its primary applications include:

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly those targeting neurological or metabolic pathways.
• Organic Synthesis Research: Used in academic and industrial R&D for constructing complex heterocyclic systems and exploring new chemical spaces.
• Fine Chemical Production: Employed in the manufacture of high-value, low-volume specialty chemicals for advanced applications.
• Bioconjugate Chemistry: Potential use in creating labeled compounds or probes for biochemical research due to its functionalizable carboxylic acid group.
• Agrochemical Research: May serve as a precursor in developing new active ingredients for crop protection products.

Basic Information

Product Name	Pyrrolo[3,4-D]Imidazole-5(1H)-Butyric Acid, Hexahydro-4-Methyl-2-Oxo-, Stereoisomer (8Ci)
CAS No.	802611-55-8
Molecular Formula	C11H17N3O3
Molecular Weight	239.27 g/mol
Synonyms	Hexahydro-4-methyl-2-oxo-1H-pyrrolo[3,4-d]imidazole-5(4H)-butyric acid; (3aR,6aR)-Hexahydro-4-methyl-2-oxo-1H-pyrrolo[3,4-d]imidazole-5-butyric acid; Pyrrolo[3,4-d]imidazole-5-butyric acid, hexahydro-4-methyl-2-oxo-, (3aR,6aR)-; (3aR,6aR)-Hexahydro-4-methyl-2-oxo-1H-pyrrolo[3,4-d]imidazole-5(4H)-butyric acid; Stereoisomer (8CI); 1H-Pyrrolo[3,4-d]imidazole-5-butyric acid, hexahydro-4-methyl-2-oxo-, (3aR,6aR)-
EINECS	Contact for details

Quality Control

We supply this advanced intermediate under a rigorous quality management system. Each batch is produced and analyzed to meet exacting standards suitable for research and pharmaceutical development. Certificates of Analysis (COA) are provided, detailing purity, identity, and impurity profiles as determined by advanced analytical techniques including HPLC, NMR, and MS. Our commitment ensures reliable batch-to-batch consistency and traceability for your critical projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to prevent moisture absorption, which may affect stability and handling properties. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.